MANY MINDEDJehovah’s Witnesses update blood policy to expand medical product access
Jehovah’s Witnesses updated their blood policy on September 19, 2026, enabling members to receive blood-derived products including plasma, platelets, red blood cells, and white blood cells for medical use. The policy maintains a ban on whole-blood transfusions and blood donation for medical products, but permits individual members to decide whether to donate blood for medical purposes. This revision represents the second update to their blood policy in 2026. The organization reported 1.3 million U.S. members as of 2025 and 9.2 million global members across 200+ countries and territories.
This change addresses a longstanding restriction that previously prevented members from accessing blood-derived medical treatments. By allowing blood-derived products while retaining the ban on whole-blood transfusions, the policy provides greater flexibility for members who require transfusions without compromising their religious beliefs. The mechanism shifts from universal prohibition to individual choice, potentially expanding access for patients who need transfusions but cannot donate blood.
For health access, this update moves toward reducing religious barriers to blood transfusions. However, the policy remains controversial and does not guarantee immediate access—members must still choose whether to participate in the system. The organization’s second policy update in 2026 suggests ongoing refinement of this approach. The source notes the change is described as controversial in their reporting.
Source: STAT